Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical pharmacokinetics and drug-drug interaction of ilaprazole
ChiCTR-TNC-10000897Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ilaprazole in duodenal ulcer (9 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoints: Metabolite of ilaprazole, Blood concentration of ilaprazole and 2 more. Started May 2008; status: completed.
02
Drugs
ilaprazole
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on ChiCTR-TNC-10000897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10000897.